SCHEMBL660685

SCHEMBL660685

O=C(CN1C=CCC(c2cc(COc3ccccc3)[nH]n2)=C1)c1cccs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
TSHR P16473 2/20 0.40
LMNA P02545 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.38
KCNA5 P22460 1/20 0.37
ABL1 P00519 1/20 0.36
GRIN1 Q05586 4/20 0.35
GRIN2B Q13224 4/20 0.35
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.34
CPT2 P23786 1/20 0.34
CPT1A P50416 1/20 0.34
HPGD P15428 3/20 0.33
MAPT P10636 2/20 0.33
KDM4E B2RXH2 2/20 0.33
GAA P10253 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL298661 0.82 KMT2A (0.37) ALDH1A1SMN1; SMN2TSHRLMNAL3MBTL1
SCHEMBL661076 0.79 ALDH1A1 (0.33) ALDH1A1TSHRGRIN1GRIN2BMAPT
SCHEMBL297726 0.79 MAPT (0.38) ALDH1A1SMN1; SMN2TSHRLMNAGRIN1
SCHEMBL661279 0.79 HPGD (0.37) ALDH1A1LMNARAB9ANPC1HPGD
SCHEMBL287222 0.78 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2TSHRLMNAABL1
SCHEMBL661658 0.74 GRM5 (0.38) ALDH1A1SMN1; SMN2TSHRLMNAHPGD
SCHEMBL297066 0.74 SMN1; SMN2 (0.37) ALDH1A1SMN1; SMN2TSHRL3MBTL1GRIN1
SCHEMBL287412 0.73 COMT (0.41) ALDH1A1TSHRHPGDMAPT
SCHEMBL287429 0.72 NPSR1 (0.36) ALDH1A1SMN1; SMN2TSHRLMNAL3MBTL1
SCHEMBL287279 0.71 GRM5 (0.39) ALDH1A1SMN1; SMN2TSHRLMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US claimed
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS AGER, REN, AGT ALDH1A1 676/4885SMN1; SMN2 640/4885TSHR 4816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.